0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Testosterone Undecylate (TU) Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-1F6137
Home | Market Reports | Health| Men s Health
Global Testosterone Undecylate TU Market Insights and Forecast to 2028
BUY CHAPTERS

Global Testosterone Undecylate (TU) Market Research Report 2025

Code: QYRE-Auto-1F6137
Report
September 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Testosterone Undecylate (TU) Market

The global market for Testosterone Undecylate (TU) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position.It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency.
North American market for Testosterone Undecylate (TU) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Testosterone Undecylate (TU) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Testosterone Undecylate (TU) in Primary Hypogonadism is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Testosterone Undecylate (TU) include Organon, Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Clarus Therapeutics, Zhejiang Xianju Pharmaceutical, Zhejiang Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Testosterone Undecylate (TU), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Testosterone Undecylate (TU).
The Testosterone Undecylate (TU) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Testosterone Undecylate (TU) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Testosterone Undecylate (TU) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Testosterone Undecylate (TU) Market Report

Report Metric Details
Report Name Testosterone Undecylate (TU) Market
Segment by Type
  • Injection
  • Oral
Segment by Application
  • Primary Hypogonadism
  • Hypogonadotropic Hypogonadism
  • Late-Onset Hypogonadism
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Organon, Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Clarus Therapeutics, Zhejiang Xianju Pharmaceutical, Zhejiang Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Testosterone Undecylate (TU) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Testosterone Undecylate (TU) Market report?

Ans: The main players in the Testosterone Undecylate (TU) Market are Organon, Bayer AG, Endo Pharmaceuticals, Merck Sharp & Dohme, Taro Pharmaceutical, Cipla, Clarus Therapeutics, Zhejiang Xianju Pharmaceutical, Zhejiang Medicine

What are the Application segmentation covered in the Testosterone Undecylate (TU) Market report?

Ans: The Applications covered in the Testosterone Undecylate (TU) Market report are Primary Hypogonadism, Hypogonadotropic Hypogonadism, Late-Onset Hypogonadism

What are the Type segmentation covered in the Testosterone Undecylate (TU) Market report?

Ans: The Types covered in the Testosterone Undecylate (TU) Market report are Injection, Oral

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Testosterone Undecylate (TU) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Injection
1.2.3 Oral
1.3 Market by Application
1.3.1 Global Testosterone Undecylate (TU) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Primary Hypogonadism
1.3.3 Hypogonadotropic Hypogonadism
1.3.4 Late-Onset Hypogonadism
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Testosterone Undecylate (TU) Market Perspective (2020-2031)
2.2 Global Testosterone Undecylate (TU) Growth Trends by Region
2.2.1 Global Testosterone Undecylate (TU) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Testosterone Undecylate (TU) Historic Market Size by Region (2020-2025)
2.2.3 Testosterone Undecylate (TU) Forecasted Market Size by Region (2026-2031)
2.3 Testosterone Undecylate (TU) Market Dynamics
2.3.1 Testosterone Undecylate (TU) Industry Trends
2.3.2 Testosterone Undecylate (TU) Market Drivers
2.3.3 Testosterone Undecylate (TU) Market Challenges
2.3.4 Testosterone Undecylate (TU) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Testosterone Undecylate (TU) Players by Revenue
3.1.1 Global Top Testosterone Undecylate (TU) Players by Revenue (2020-2025)
3.1.2 Global Testosterone Undecylate (TU) Revenue Market Share by Players (2020-2025)
3.2 Global Testosterone Undecylate (TU) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Testosterone Undecylate (TU) Revenue
3.4 Global Testosterone Undecylate (TU) Market Concentration Ratio
3.4.1 Global Testosterone Undecylate (TU) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Testosterone Undecylate (TU) Revenue in 2024
3.5 Global Key Players of Testosterone Undecylate (TU) Head office and Area Served
3.6 Global Key Players of Testosterone Undecylate (TU), Product and Application
3.7 Global Key Players of Testosterone Undecylate (TU), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Testosterone Undecylate (TU) Breakdown Data by Type
4.1 Global Testosterone Undecylate (TU) Historic Market Size by Type (2020-2025)
4.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2026-2031)
5 Testosterone Undecylate (TU) Breakdown Data by Application
5.1 Global Testosterone Undecylate (TU) Historic Market Size by Application (2020-2025)
5.2 Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Testosterone Undecylate (TU) Market Size (2020-2031)
6.2 North America Testosterone Undecylate (TU) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Testosterone Undecylate (TU) Market Size by Country (2020-2025)
6.4 North America Testosterone Undecylate (TU) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Testosterone Undecylate (TU) Market Size (2020-2031)
7.2 Europe Testosterone Undecylate (TU) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Testosterone Undecylate (TU) Market Size by Country (2020-2025)
7.4 Europe Testosterone Undecylate (TU) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Testosterone Undecylate (TU) Market Size (2020-2031)
8.2 Asia-Pacific Testosterone Undecylate (TU) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2020-2025)
8.4 Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Testosterone Undecylate (TU) Market Size (2020-2031)
9.2 Latin America Testosterone Undecylate (TU) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Testosterone Undecylate (TU) Market Size by Country (2020-2025)
9.4 Latin America Testosterone Undecylate (TU) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Testosterone Undecylate (TU) Market Size (2020-2031)
10.2 Middle East & Africa Testosterone Undecylate (TU) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2020-2025)
10.4 Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Organon
11.1.1 Organon Company Details
11.1.2 Organon Business Overview
11.1.3 Organon Testosterone Undecylate (TU) Introduction
11.1.4 Organon Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.1.5 Organon Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Testosterone Undecylate (TU) Introduction
11.2.4 Bayer AG Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.2.5 Bayer AG Recent Development
11.3 Endo Pharmaceuticals
11.3.1 Endo Pharmaceuticals Company Details
11.3.2 Endo Pharmaceuticals Business Overview
11.3.3 Endo Pharmaceuticals Testosterone Undecylate (TU) Introduction
11.3.4 Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.3.5 Endo Pharmaceuticals Recent Development
11.4 Merck Sharp & Dohme
11.4.1 Merck Sharp & Dohme Company Details
11.4.2 Merck Sharp & Dohme Business Overview
11.4.3 Merck Sharp & Dohme Testosterone Undecylate (TU) Introduction
11.4.4 Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.4.5 Merck Sharp & Dohme Recent Development
11.5 Taro Pharmaceutical
11.5.1 Taro Pharmaceutical Company Details
11.5.2 Taro Pharmaceutical Business Overview
11.5.3 Taro Pharmaceutical Testosterone Undecylate (TU) Introduction
11.5.4 Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.5.5 Taro Pharmaceutical Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Testosterone Undecylate (TU) Introduction
11.6.4 Cipla Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.6.5 Cipla Recent Development
11.7 Clarus Therapeutics
11.7.1 Clarus Therapeutics Company Details
11.7.2 Clarus Therapeutics Business Overview
11.7.3 Clarus Therapeutics Testosterone Undecylate (TU) Introduction
11.7.4 Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.7.5 Clarus Therapeutics Recent Development
11.8 Zhejiang Xianju Pharmaceutical
11.8.1 Zhejiang Xianju Pharmaceutical Company Details
11.8.2 Zhejiang Xianju Pharmaceutical Business Overview
11.8.3 Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Introduction
11.8.4 Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.8.5 Zhejiang Xianju Pharmaceutical Recent Development
11.9 Zhejiang Medicine
11.9.1 Zhejiang Medicine Company Details
11.9.2 Zhejiang Medicine Business Overview
11.9.3 Zhejiang Medicine Testosterone Undecylate (TU) Introduction
11.9.4 Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2020-2025)
11.9.5 Zhejiang Medicine Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Testosterone Undecylate (TU) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Injection
 Table 3. Key Players of Oral
 Table 4. Global Testosterone Undecylate (TU) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Testosterone Undecylate (TU) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Testosterone Undecylate (TU) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Testosterone Undecylate (TU) Market Share by Region (2020-2025)
 Table 8. Global Testosterone Undecylate (TU) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Testosterone Undecylate (TU) Market Share by Region (2026-2031)
 Table 10. Testosterone Undecylate (TU) Market Trends
 Table 11. Testosterone Undecylate (TU) Market Drivers
 Table 12. Testosterone Undecylate (TU) Market Challenges
 Table 13. Testosterone Undecylate (TU) Market Restraints
 Table 14. Global Testosterone Undecylate (TU) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Testosterone Undecylate (TU) Market Share by Players (2020-2025)
 Table 16. Global Top Testosterone Undecylate (TU) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Undecylate (TU) as of 2024)
 Table 17. Ranking of Global Top Testosterone Undecylate (TU) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Testosterone Undecylate (TU) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Testosterone Undecylate (TU), Headquarters and Area Served
 Table 20. Global Key Players of Testosterone Undecylate (TU), Product and Application
 Table 21. Global Key Players of Testosterone Undecylate (TU), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Testosterone Undecylate (TU) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2020-2025)
 Table 25. Global Testosterone Undecylate (TU) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Testosterone Undecylate (TU) Revenue Market Share by Type (2026-2031)
 Table 27. Global Testosterone Undecylate (TU) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Testosterone Undecylate (TU) Revenue Market Share by Application (2020-2025)
 Table 29. Global Testosterone Undecylate (TU) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Testosterone Undecylate (TU) Revenue Market Share by Application (2026-2031)
 Table 31. North America Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Testosterone Undecylate (TU) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Testosterone Undecylate (TU) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Testosterone Undecylate (TU) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Testosterone Undecylate (TU) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Testosterone Undecylate (TU) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Testosterone Undecylate (TU) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Testosterone Undecylate (TU) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Testosterone Undecylate (TU) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Testosterone Undecylate (TU) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Testosterone Undecylate (TU) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Organon Company Details
 Table 47. Organon Business Overview
 Table 48. Organon Testosterone Undecylate (TU) Product
 Table 49. Organon Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 50. Organon Recent Development
 Table 51. Bayer AG Company Details
 Table 52. Bayer AG Business Overview
 Table 53. Bayer AG Testosterone Undecylate (TU) Product
 Table 54. Bayer AG Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 55. Bayer AG Recent Development
 Table 56. Endo Pharmaceuticals Company Details
 Table 57. Endo Pharmaceuticals Business Overview
 Table 58. Endo Pharmaceuticals Testosterone Undecylate (TU) Product
 Table 59. Endo Pharmaceuticals Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 60. Endo Pharmaceuticals Recent Development
 Table 61. Merck Sharp & Dohme Company Details
 Table 62. Merck Sharp & Dohme Business Overview
 Table 63. Merck Sharp & Dohme Testosterone Undecylate (TU) Product
 Table 64. Merck Sharp & Dohme Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 65. Merck Sharp & Dohme Recent Development
 Table 66. Taro Pharmaceutical Company Details
 Table 67. Taro Pharmaceutical Business Overview
 Table 68. Taro Pharmaceutical Testosterone Undecylate (TU) Product
 Table 69. Taro Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 70. Taro Pharmaceutical Recent Development
 Table 71. Cipla Company Details
 Table 72. Cipla Business Overview
 Table 73. Cipla Testosterone Undecylate (TU) Product
 Table 74. Cipla Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 75. Cipla Recent Development
 Table 76. Clarus Therapeutics Company Details
 Table 77. Clarus Therapeutics Business Overview
 Table 78. Clarus Therapeutics Testosterone Undecylate (TU) Product
 Table 79. Clarus Therapeutics Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 80. Clarus Therapeutics Recent Development
 Table 81. Zhejiang Xianju Pharmaceutical Company Details
 Table 82. Zhejiang Xianju Pharmaceutical Business Overview
 Table 83. Zhejiang Xianju Pharmaceutical Testosterone Undecylate (TU) Product
 Table 84. Zhejiang Xianju Pharmaceutical Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 85. Zhejiang Xianju Pharmaceutical Recent Development
 Table 86. Zhejiang Medicine Company Details
 Table 87. Zhejiang Medicine Business Overview
 Table 88. Zhejiang Medicine Testosterone Undecylate (TU) Product
 Table 89. Zhejiang Medicine Revenue in Testosterone Undecylate (TU) Business (2020-2025) & (US$ Million)
 Table 90. Zhejiang Medicine Recent Development
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources
 Table 94. Authors List of This Report


List of Figures
 Figure 1. Testosterone Undecylate (TU) Picture
 Figure 2. Global Testosterone Undecylate (TU) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Testosterone Undecylate (TU) Market Share by Type: 2024 VS 2031
 Figure 4. Injection Features
 Figure 5. Oral Features
 Figure 6. Global Testosterone Undecylate (TU) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Testosterone Undecylate (TU) Market Share by Application: 2024 VS 2031
 Figure 8. Primary Hypogonadism Case Studies
 Figure 9. Hypogonadotropic Hypogonadism Case Studies
 Figure 10. Late-Onset Hypogonadism Case Studies
 Figure 11. Testosterone Undecylate (TU) Report Years Considered
 Figure 12. Global Testosterone Undecylate (TU) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Testosterone Undecylate (TU) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Testosterone Undecylate (TU) Market Share by Region: 2024 VS 2031
 Figure 15. Global Testosterone Undecylate (TU) Market Share by Players in 2024
 Figure 16. Global Top Testosterone Undecylate (TU) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Undecylate (TU) as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Testosterone Undecylate (TU) Revenue in 2024
 Figure 18. North America Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Testosterone Undecylate (TU) Market Share by Country (2020-2031)
 Figure 20. United States Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Testosterone Undecylate (TU) Market Share by Country (2020-2031)
 Figure 24. Germany Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Testosterone Undecylate (TU) Market Share by Region (2020-2031)
 Figure 32. China Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Testosterone Undecylate (TU) Market Share by Country (2020-2031)
 Figure 40. Mexico Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Testosterone Undecylate (TU) Market Share by Country (2020-2031)
 Figure 44. Turkey Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Testosterone Undecylate (TU) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Organon Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 48. Bayer AG Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 49. Endo Pharmaceuticals Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 50. Merck Sharp & Dohme Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 51. Taro Pharmaceutical Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 52. Cipla Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 53. Clarus Therapeutics Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 54. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 55. Zhejiang Medicine Revenue Growth Rate in Testosterone Undecylate (TU) Business (2020-2025)
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

RELATED REPORTS

Global Testicular Cancer Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26B6701
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Biomarker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12M6232
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Benign Prostatic Hyperplasia Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39G5907
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Prostate Cancer Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7B2445
Mon Sep 08 00:00:00 UTC 2025

Add to Cart